MichelleXiaMD

Anatomic Pathology, Clinical Pathology

Physician

Dr. Xia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of Texas Medical Branch HospitalsResidency, Pathology-Anatomic and Clinical, 2012 - 2016
University of Texas Medical Branch HospitalsResidency, Pathology-Anatomic and Clinical, 2011 - 2015
University of Texas Southwestern Medical SchoolClass of 2011

PubMed

14 citations
DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
Iván González, Bella Goyal, Michelle Xia, Reetesh K. Pai, Changqing Ma> ;Human Pathology. 2019 Mar 1
6 citations
Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
Michelle Xia, Michael J. Overman, Asif Rashid, Deyali Chatterjee, Hua Wang, Matthew H.G. Katz, Jason B. Fleming, Jeffrey E. Lee, Gauri R. Varadhachary, Robert A. Wolff...> ;Human Pathology. 2015 Sep 1
1 citations
Boerhaave syndrome resulting from homicidal blunt trauma.
Michelle Xia, Stephen Pustilnik> ;The American Journal of Forensic Medicine and Pathology. 2014 Sep 1
Endoscopic ultrasound-guided fine needle aspiration of the celiac ganglion: A diagnostic pitfall.
Xia, D., Gilbert-Lewis, K. N., Bhutani, M. S., Nawgiri, R. S.> ;Cytojournal. 2012
Join now to see all

Journal Articles

Original Contribution DNA Mismatch Repair Deficiency but Not ARID1A Loss Is Associated with Prognosis in Small Intestinal Adenocarcinoma☆☆☆
Michelle D Xia, Bella Goyal, ScienceDirect

Akeso Reported 2022 Annual ResultsMarch 16th, 2023
Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic SyndromesSeptember 29th, 2023
Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGFAugust 31st, 2023